VITAL – A BARDA BAN Hub

? Reminder: Our next info session is happening TOMORROW! Don't miss this insightful session where we'll dive into VITAL’s non-dilutive funding opportunities for pre-exposure prophylaxis (PrEP) aimed at advancing innovations in delivery, distribution, and half-life extension for monoclonal antibody and/or nucleic acid platforms targeting seasonal and pandemic influenza and other respiratory viruses! ?????????????? ? When: January 17 at 10 AM ET ? Where: Online ? Registration Link: https://lnkd.in/dRGep-p5 If you haven’t already, there’s still time to register! Secure your spot now and be part of the conversation. We can’t wait to see you there!

The year might be wrapping up, but we’re charging ahead and planning for the future! Join us on January 17 for an info session to learn all about VITAL’s non-dilutive funding opportunities for pre-exposure prophylaxis (PrEP) aimed at advancing innovations in delivery, distribution, and half-life extension for monoclonal antibody and/or nucleic acid platforms targeting seasonal and pandemic influenza and other respiratory viruses! ?????????????? ? When: January 17 at 10 AM ET ? Where: Online ? Registration Link:?https://lnkd.in/dRGep-p5 This info session will allow you to get an in-depth overview of VITAL funding opportunities and address any questions you may have about the application process, eligibility, and key focus areas.

Our VITAL Accelerator Kickoff in Cambridge was a huge success! ? ? The inaugural VITAL Accelerator cohort gained invaluable insights from industry experts and began their journeys with us through intensive, hands-on deep dives and workshops. The startups not only immersed themselves Cambridge’s thriving biotech ecosystem but also built meaningful connections with fellow founders dedicated to driving innovation in the vaccine and therapeutic space.? Beyond the sessions, participants embraced every opportunity to network and collaborate, from engaging discussions during workshops to relaxed conversations at networking events. These connections and shared experiences set the stage for a transformative accelerator journey.? ? A big thank you to all our speakers and VITAL partners for generously sharing their expertise and insights: Will Adams, Greg Dombal, Dean Farmer, Arthur Hiller, Steven Laken, Neema Mayhugh, PhD, Raquel Riera, and Laura Stevens. Special thanks to Mary Larkin and the Biomedical Advanced Research and Development Authority (BARDA) team for their steadfast support of innovation in the vaccine and therapeutics space. Looking forward to seeing these companies move through our program and beyond – Auravax Therapeutics, Inc. | Avocet Bio GmbH | Cryptyx Bioscience | Cutanos GmbH | Immunyx Pharma | Macrotope Inc. | Grant Knappe at Bathe BioNanoLab | Nitro Biosciences | Sagitta Biotech | Thylacine Biotherapeutics?

Introducing the very first VITAL Biotech Accelerator Cohort! VITAL is thrilled to welcome 10 trailblazers to the inaugural Biotech Accelerator cohort, each on a mission to revolutionize health and biotech: Auravax Therapeutics, Inc. | Avocet Bio GmbH | Cryptyx Bioscience | Cutanos GmbH | Immunyx Pharma | Macrotope Inc. | Grant Knappe at Bathe BioNanoLab | Nitro Biosciences | Sagitta Biotech | Thylacine Biotherapeutics From groundbreaking respiratory therapeutics to innovative vaccine platforms, this cohort represents cutting-edge solutions to enhance pandemic preparedness and health security. Through the VITAL Biotech Accelerator, these companies will gain access to world-class mentorship, strategic industry connections, and vital resources to amplify their impact on global health. Learn about the program and its benefits here:?https://lnkd.in/dFQA-zgR Join us in celebrating the VITAL Biotech Accelerator participants as they embark on their journey to transform the future of health. Biomedical Advanced Research and Development Authority (BARDA)

? There’s still time to sign up for tomorrow’s virtual info session on non-dilutive funding opportunities for PrEP innovations! If you’re working on delivery, distribution, and half-life extension for monoclonal antibody and/or nucleic acid platforms for pre-exposure prophylaxis (PrEP) targeting seasonal and pandemic influenza and other respiratory viruses, this is your chance to learn more about VITAL's non-dilutive funding opportunities. ?? Why join? ??Get a detailed overview of the funding opportunities ??Participate in a live Q&A covering the application process, eligibility, and key focus areas ??? When: Tomorrow, Wednesday, November 13 at 11 AM ET ?? Register now: https://lnkd.in/esa_VRpE Don’t miss this opportunity to advance your innovation!

?? ????????????????: Info Session on Non-Dilutive Funding Opportunities for Pre-Exposure Prophylaxis (PrEP) Join us tomorrow for our first virtual info session on VITAL funding opportunities aimed at advancing innovations in delivery, distribution, and half-life extension for monoclonal antibody and/or nucleic acid platforms for pre-exposure prophylaxis (PrEP) targeting seasonal and pandemic influenza and other respiratory viruses! ?????? ?????????????? ? Get an in-depth overview of VITAL funding opportunities ? Address your questions about the application process, eligibility, and key focus areas during live Q&A ?? ?????????? ??????????????: ? Tomorrow, Tuesday, October 15 at 9 AM ET ???????????????????? ??????????: ? Wednesday, November 13 at 11 AM ET ? Wednesday, December 13 at 10 AM ET Register here: https://lnkd.in/esa_VRpE

Curious about non-dilutive funding opportunities to advance innovations in delivery, distribution and half-life extension for monoclonal antibody and/or nucleic acid platforms for pre-exposure prophylaxis (PrEP)? We are hosting a series of virtual info sessions to shed light on funding opportunities through VITAL. ???????? ???? ????????????: ? In-depth overview of VITAL funding opportunities and how they can support your platform approaches. ? Live Q&A to address your questions about the application process, eligibility, key focus areas, and how to increase your chances of selection. ???????????????? ???????? ????????????????:? ? Tuesday, October 15 at 9 AM ET ? Wednesday, November 13 at 11 AM ET ? Wednesday, December 13 at 10 AM ET Register and pick the time that works best for you here: https://lnkd.in/esa_VRpE Don't miss out and learn more about how VITAL can help drive your innovation forward!

Non-Dilutive Funding Opportunity! ?? Are you advancing innovative Pre-Exposure Prophylaxis (PrEP) solutions? Here’s your chance to secure non-dilutive funding to propel your platform forward! VITAL and Biomedical Advanced Research and Development Authority (BARDA) are seeking transformative approaches to enhance the delivery, biodistribution, and durability of long-acting monoclonal antibody and/or nucleic acid-based platforms for PrEP against seasonal and pandemic influenza, as well as other respiratory viruses. The focus areas are:? ? ?? ???????????????????? ???????????????? ??????????????????: Exploring long-acting solutions for upper and lower respiratory tract delivery.? ? ?? ?????????????? ????????-?????????? ??????????????????: Innovating approaches to improve durability and targeted delivery for broader protection. We’re calling on academic innovators, non-profits, and for-profit startups globally to join us in building on the success of mAbs and mRNA to revolutionize respiratory disease prevention. Apply here ?? https://lnkd.in/drw3SZXf #NucleicAcidTherapies #MonoclonalAntibodies?#RespiratoryDiseases #BioTech #Funding #PandemicPreparedness

Are you a #biotech innovator looking to take your startup to the next level? Join us for a virtual info session to learn more about the Biotech Accelerator Program and Funding Awards made available through VITAL. Multiple Webinars Available! Choose the date and time that works best for you: ? Thursday, July 18 at 9 AM EST ? Thursday, July 18 at 3 PM EST ? Wednesday, August 7 at 3 PM EST ? Thursday, August 8 at 9 AM EST During these sessions, you will:? ?? Gain insights into the VITAL Biotech Accelerator Program? ?? Learn about the funding opportunities ranging from $50K to $200K ?? Get your questions answered in an interactive Q&A segment This is your chance to learn more about how the VITAL program can accelerate your growth. Don’t miss this opportunity to propel your biotech startup forward. See you there! Sign up here ?? https://lnkd.in/dqfHj2Cq #Biotech #GlobalHealth #Vaccine #Therapeutics Start2 Group Advise Connect Inspire, LLC BioLabs

Are you ready to make a global impact? The VITAL Biotech Accelerator Program is now accepting applications! This is your opportunity to drive global health solutions. What we offer: ?? Expert Mentoring: Receive highly individualized mentoring?tailored to your company’s needs. ?? Extensive Network: Access a network of over 250 healthtech and biotech mentors. ?? No Cost, No Equity: Benefit from a fully funded, equity-free program. We are looking for innovative startups and university projects specializing in therapeutics and vaccines aimed at combating pandemics and enhancing global health security. Apply to the VITAL Biotech Accelerator Program and make a global impact! Deadline: August 23, 2024. ??? https://lnkd.in/dFQA-zgR? #HealthTech #GlobalHealth #HealthSecurity #Vaccines #Therapeutics #Biotech